Eye Health News and Research

Latest Eye Health News and Research

Phase 3 clinical trial results of Inspire Pharmaceuticals' PROLACRIA announced

Inspire Pharmaceuticals, Inc. announced today that its Phase 3 clinical trial (Trial 03-113) of PROLACRIA™ (diquafosol tetrasodium ophthalmic solution) 2% for the treatment of dry eye disease did not meet its primary endpoint (p = 0.526) or its secondary endpoint (p = 0.368).

21 Jan 2010

UnitedHealth Group announces its revenues and net earnings in 2009

UnitedHealth Group today reported growth in revenues and net earnings per share in 2009. The Company earned $0.81 per share in the fourth quarter, bringing full year 2009 net earnings to $3.24 per share.

21 Jan 2010

6th Annual Diabetes Conference to feature ocular drug delivery in diabetic retinopathy

pSivida Corp., a leader in the development of tiny, sustained-release drug delivery technologies, with two of the only three ophthalmic sustained-release delivery products approved by the FDA for treatment of back of the eye diseases, announced that its chief executive officer, Dr. Paul Ashton, will discuss ocular drug delivery in diabetic retinopathy during a presentation at the 6th Annual Diabetes Conference in London, on Friday, January 22.

21 Jan 2010

U.S. veterinarians join coalition to address ongoing humanitarian relief efforts in Haiti

The American Veterinary Medical Association (AVMA) and American Veterinary Medical Foundation (AVMF) have joined a coalition of other animal health and welfare groups to help address the ongoing humanitarian relief efforts in Haiti following the January 12 earthquake that devastated the country.

21 Jan 2010

Lexicon Pharmaceuticals reports positive results from its LX4211 Phase 2 trial in type 2 diabetic patients

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day, orally-delivered, small molecule drug candidate that inhibits the sodium-dependent glucose transporter 2 (SGLT2), lowering the accumulation of glucose in the body and reducing caloric load.

20 Jan 2010

Speaker and House Majority Leader hold press availability following Democratic leadership meeting

Speaker Nancy Pelosi, House Majority Leader Steny Hoyer and House Majority Whip James E. Clyburn held a press availability this afternoon in the Capitol following a Democratic leadership meeting.

20 Jan 2010

$SIR supports use of vertebral augmentation for patients with spine fractures$

SIR supports use of vertebral augmentation for patients with spine fractures

Given the current controversy over vertebroplasty-a minimally invasive treatment performed by interventional radiologists in individuals with painful osteoporotic vertebral compression fractures that fail to respond to conventional medical therapy-what's a patient to do?

20 Jan 2010

Davis Vision's "Order Online to Win" promotion awarded to Dr. Candice Macri

Dr. Candice Macri, a Pittsburgh-area optometrist, has won Davis Vision's "Order Online to Win" promotion. On Wednesday, Jan. 20, Davis Vision representatives will visit Dr. Macri's office in New Castle, Pa. to present her prize, a trip to Miami for the Big Game on Sunday, Feb. 7.

20 Jan 2010

Zecotek Photonics' Real-Time 3D2D Display System exhibited in Zurich

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that its Real-Time 3D2D Display System is exhibited in Zurich, Switzerland to a select number of European display manufacturers.

20 Jan 2010

Cognitive fluctuations more likely to occur in older persons with Alzheimer's disease

Cognitive fluctuations, or episodes when train of thought temporarily is lost, are more likely to occur in older persons who are developing Alzheimer's disease than in their healthy peers, according to scientists at Washington University School of Medicine in St. Louis.

19 Jan 2010

Alcon to acquire U.S. rights to Sirion Therapeutics' Durezol and Zirgan

Alcon, the world’s leader in eye care, announced today that it will purchase the rights in the United States for two FDA-approved topical eye care products from Sirion Therapeutics, Inc. The two products purchased are Durezol™, a marketed ophthalmic corticosteroid approved for the treatment of inflammation and pain associated with eye surgery, and Zirgan™, a recently approved antiviral for the treatment of acute herpetic keratitis (corneal ulcers).

18 Jan 2010

NIH awards IU School of Optometry $2.35M for glaucoma research

An Indiana University School of Optometry researcher's ongoing work to improve testing for and treatment of one of the world's leading causes of blindness will advance with support from a $2.35 million grant from the National Institutes of Health.

18 Jan 2010

This year's Aegean Cornea Conference to celebrate 20th Anniversary of LASIK Surgery

The Institute of Vision and Optics at the University of Crete announced today that this year’s Aegean Cornea Conference will celebrate the 20th Anniversary of LASIK surgery. The biennial event will feature world leaders in cornea, cataract and refractive surgery as well as presentations on medical and scientific breakthroughs in the field.

18 Jan 2010

Over-the-counter medications can help manage minor ailments

Nonprescription medications in the home medicine cabinet could save a trip to the doctor. The January issue of Mayo Clinic Health Letter lists more than a dozen over-the-counter medications that can help manage minor ailments.

18 Jan 2010

Breakthrough discovery could lead to new treatments for a variety of CNS disorders

A breakthrough discovery by scientists at the University of Kentucky could someday lead to new treatments for a variety of diseases of the brain, spinal cord and the eye.

18 Jan 2010

UCL scientists: Simple eye test can help detect and diagnose major neurological diseases

A simple and inexpensive eye test could aid detection and diagnosis of major neurological diseases such as Alzheimer's at an earlier stage than is currently possible, according to new research by UCL scientists.

18 Jan 2010

New technique can restore facial movements in paralytic patients

Surgeons from UC Davis Medical Center have demonstrated that artificial muscles can restore the ability of patients with facial paralysis to blink, a development that could benefit the thousands of people each year who no longer are able to close their eyelids due to combat-related injuries, stroke, nerve injury or facial surgery.

18 Jan 2010

Eye Health News and Research

Latest Eye Health News and Research

Phase 3 clinical trial results of Inspire Pharmaceuticals' PROLACRIA announced

UnitedHealth Group announces its revenues and net earnings in 2009

6th Annual Diabetes Conference to feature ocular drug delivery in diabetic retinopathy

U.S. veterinarians join coalition to address ongoing humanitarian relief efforts in Haiti

Lexicon Pharmaceuticals reports positive results from its LX4211 Phase 2 trial in type 2 diabetic patients

Speaker and House Majority Leader hold press availability following Democratic leadership meeting

SIR supports use of vertebral augmentation for patients with spine fractures

Davis Vision's "Order Online to Win" promotion awarded to Dr. Candice Macri

Zecotek Photonics' Real-Time 3D2D Display System exhibited in Zurich

Cognitive fluctuations more likely to occur in older persons with Alzheimer's disease

Alcon to acquire U.S. rights to Sirion Therapeutics' Durezol and Zirgan

NIH awards IU School of Optometry $2.35M for glaucoma research

This year's Aegean Cornea Conference to celebrate 20th Anniversary of LASIK Surgery

Over-the-counter medications can help manage minor ailments

Breakthrough discovery could lead to new treatments for a variety of CNS disorders

UCL scientists: Simple eye test can help detect and diagnose major neurological diseases

New technique can restore facial movements in paralytic patients

Dramatically enhanced image contrast could revolutionize diagnostics and therapeutics

HHMI: Distinct cancer-causing mutations in neighboring cells can cooperate to produce tumors

Researchers discover potential treatment for blinding disease

Genetics & Genomics - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in